- Home
- PROK vs ZTR Comparison
PROK vs ZTR Comparison
Compare PROK & ZTR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PROK
- ZTR
- Stock Information
- Founded
- PROK 2015
- ZTR 1988
- Country
- PROK United States
- ZTR Australia
- Employees
- PROK N/A
- ZTR N/A
- Industry
- PROK Biotechnology: Biological Products (No Diagnostic Substances)
- ZTR Investment Managers
- Sector
- PROK Health Care
- ZTR Finance
- Exchange
- PROK Nasdaq
- ZTR Nasdaq
- Market Cap
- PROK 417.1M
- ZTR 350.0M
- IPO Year
- PROK N/A
- ZTR N/A
- Fundamental
- Price
- PROK $2.97
- ZTR $6.57
- Analyst Decision
- PROK Strong Buy
- ZTR
- Analyst Count
- PROK 4
- ZTR 0
- Target Price
- PROK $6.25
- ZTR N/A
- AVG Volume (30 Days)
- PROK 2.1M
- ZTR 219.4K
- Earning Date
- PROK 11-11-2025
- ZTR 01-01-0001
- Dividend Yield
- PROK N/A
- ZTR 12.09%
- EPS Growth
- PROK N/A
- ZTR N/A
- EPS
- PROK N/A
- ZTR N/A
- Revenue
- PROK $527,000.00
- ZTR N/A
- Revenue This Year
- PROK $427.89
- ZTR N/A
- Revenue Next Year
- PROK N/A
- ZTR N/A
- P/E Ratio
- PROK N/A
- ZTR N/A
- Revenue Growth
- PROK N/A
- ZTR N/A
- 52 Week Low
- PROK $0.46
- ZTR $4.50
- 52 Week High
- PROK $7.13
- ZTR $6.60
- Technical
- Relative Strength Index (RSI)
- PROK 55.05
- ZTR 62.64
- Support Level
- PROK $2.80
- ZTR $6.45
- Resistance Level
- PROK $3.28
- ZTR $6.66
- Average True Range (ATR)
- PROK 0.27
- ZTR 0.07
- MACD
- PROK 0.01
- ZTR 0.00
- Stochastic Oscillator
- PROK 57.52
- ZTR 69.49
About PROK ProKidney Corp.
ProKidney Corp is a clinical-stage biotechnology company with a transformative proprietary cell therapy platform capable of treating multiple chronic kidney diseases using a patient's cells isolated from the patient intended for treatment. Its product candidate, REACT (Renal Autologous Cell Therapy) is a disease-modifying cell therapy made from a patient's renal cells. REACT has the potential to slow and stabilize the progression of chronic kidney disease. The company's pipeline consists of the development program for severe diabetic kidney disease.
About ZTR Virtus Total Return Fund Inc.
Virtus Total Return Fund Inc is a closed-end, diversified management investment company. Its investment objective of capital appreciation, with current income as a secondary objective. The Fund seeks to meet its objectives through a balance of equity and fixed income investments.